Croda International Plc (LON:CRDA - Get Free Report) insider Tom Brophy bought 5 shares of the company's stock in a transaction dated Tuesday, July 15th. The stock was purchased at an average cost of GBX 2,987 ($40.11) per share, for a total transaction of £149.35 ($200.55).
Tom Brophy also recently made the following trade(s):
- On Thursday, May 29th, Tom Brophy bought 54 shares of Croda International stock. The stock was purchased at an average cost of GBX 3,070 ($41.22) per share, for a total transaction of £1,657.80 ($2,226.13).
- On Thursday, May 29th, Tom Brophy bought 90 shares of Croda International stock. The stock was purchased at an average cost of GBX 3,070 ($41.22) per share, for a total transaction of £2,763 ($3,710.22).
- On Thursday, May 29th, Tom Brophy purchased 55 shares of Croda International stock. The shares were bought at an average price of GBX 3,070 ($41.22) per share, with a total value of £1,688.50 ($2,267.36).
- On Thursday, May 29th, Tom Brophy purchased 70 shares of Croda International stock. The shares were bought at an average price of GBX 3,070 ($41.22) per share, with a total value of £2,149 ($2,885.73).
Croda International Stock Performance
Croda International stock traded down GBX 31 ($0.42) on Friday, hitting GBX 2,846 ($38.22). The company's stock had a trading volume of 278,191 shares, compared to its average volume of 1,127,885. The firm has a market cap of £3.98 billion, a P/E ratio of 24.46, a price-to-earnings-growth ratio of 1.40 and a beta of 0.74. The company has a quick ratio of 2.25, a current ratio of 2.72 and a debt-to-equity ratio of 30.90. The company has a fifty day moving average price of GBX 3,043.01 and a 200-day moving average price of GBX 3,065.15. Croda International Plc has a one year low of GBX 2,551 ($34.26) and a one year high of GBX 4,335 ($58.21).
Wall Street Analyst Weigh In
A number of research firms have issued reports on CRDA. Berenberg Bank reiterated a "buy" rating and issued a GBX 3,800 ($51.03) target price on shares of Croda International in a research note on Thursday, April 24th. Citigroup reduced their target price on shares of Croda International from GBX 3,550 ($47.67) to GBX 3,300 ($44.31) and set a "neutral" rating for the company in a research note on Tuesday, April 29th.
View Our Latest Report on Croda International
Croda International Company Profile
(
Get Free Report)
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.
Read More

Before you consider Croda International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Croda International wasn't on the list.
While Croda International currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.